Three doctors indicted for conspiring to distribute oxycodone
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Breadcrumb

  • Home
  • Three doctors indicted for conspiring to distribute oxycodone

Three doctors indicted for conspiring to distribute oxycodone

February 13, 2020
|
Share Article
|
Download Press Release
For Immediate Release
Contact:
Phone Number: (571) 362-5149

Helped by patients and staff

ST. LOUIS – Eleven individuals were indicted today by a federal grand jury for conspiracy to distribute controlled medications, such as oxycodone, without a legitimate medical purpose, obtaining controlled medication by deceit and subterfuge, paying and receiving illegal kickbacks for referrals to lab for urine tests of the patients, and submitting false claims to Medicare and other health insurers.

The Drug Enforcement Administration St. Louis Division, the Attorney General’s Medicaid Fraud Control Unit, the Federal Bureau of Investigation, the Defense Criminal Investigative Service, and the Department of Health and Human Services – Office of Inspector General are investigating this case.

Those indicted were:

Asim Muhammad Ali, M.D., 49, of Creve Coeur;
Alexis Dorjay Butler, 32, of Bellefontaine Neighbors;
Shaunta C. Crosby, 33, of Ferguson;
Erin Melissa Herman, 35, of Oakville;
Vladimir Kogan, 39, of Afton;
Jerry Dale Leech, D.C., 47, of Creve Coeur;
Stanley L. Librach, M.D., 58, of Chesterfield;
Denis J. Mikhlin, 40, of Chesterfield;
Ebony R. Price, 37, of St. Louis;
Erica T. Spates, 32, of Berkley; and
Tijuana A. Spates, 36, of Jennings.

According to the indictment, Dr. Asim Muhammad Ali and Dr. Stanley Librach, medical doctors, and Dr. Jerry Dale Leech, a chiropractor, and Denis J. Mikhlin illegally wrote and distributed hundreds of prescriptions for oxycodone, Oxycontin, hydromorphone, and fentanyl for patients whom Dr. Ali and Dr. Librach did not see, examine, or evaluate.

One day a week for about two hours, Dr. Ali or Dr. Librach went to the American Pain Institute or Institute for Pain Management, to pre-sign stacks of prescriptions, which were given to API and IPM patients during the next week or two. Dr. Ali and Dr. Librach continued to write prescriptions for controlled substance drugs, despite many patients repeatedly tested negative for the prescribed drugs and positive for illegal street drugs.

According to the indictment, Dr. Leech, an owner of API and chief of staff for IPM, Denis Mikhlin, the owner of Doctors on the Go, and the other defendants bought and sold prescriptions for controlled substances written in the name of Dr. Librach and other doctors. Dr. Leech received between $200 and $500 for each script he sold, receiving on some occasions as much as $5,000.  Dr. Leech and Mikhlin also identified or had other co-defendants identify persons whose names could be used on fraudulent scripts. The patients were paid in cash or with some of the pills. Dr. Ali, one of the co-owners of Central Diagnostic Laboratory paid illegal kickbacks to Dr. Leech, Dr. Librach, and Mikhlin for the referral of drug tests that they sent to CDL.

“Doctors and trained practitioners know better than anyone the twin dangers of addiction and overdose that come with powerful narcotics,” said DEA St. Louis Division Special Agent in Charge William Callahan. "DEA will investigate doctors, like these ones, who prescribe a controlled substance outside the normal course of professional practice and for no legitimate medical purpose to stop their illegal practices."

"According to the Centers for Disease Control and Prevention, the majority of overdose deaths in this country involved prescription or illicit opioid," said Special Agent in Charge Richard Quinn of the FBI St. Louis Division. "It is appalling that any health care professional would knowingly fuel this epidemic rather than help stop it."

“Doctors who prescribe medically unnecessary and potentially addictive drugs are a threat to their patients, and their actions will not be tolerated,” said Special Agent in Charge for the Office of Inspector General of the U.S. Department of Health and Human Services Curt L. Muller. “We will continue working closely with our State and Federal law enforcement partners to protect patients and the government healthcare programs on which they depend.”

If convicted, each count carries a maximum penalty of 10 years in prison and a $250,000 fine. In determining the actual sentences, a judge is required to consider the U.S. Sentencing Guidelines, which provide recommended sentencing ranges.

Charges set forth in the indictment are merely accusations and do not constitute proof of guilt. Every defendant is presumed to be innocent unless and until proven guilty. 

Download Press Release
###
Oxycodone Fentanyl Hydromorphone
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Michael A. Davis Special Agent in Charge - St. Louis
@DEAStLouisDiv
  • Facebook
  • X
  • Email
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster